Abstract 4141101: Loss of Chondroitin Sulfate N-acetylgalactosaminyltransferase-2 (ChGn-2) Impairs Thrombus Resolution in Mice Model

Background: Deep vein thrombosis (DVT) remains a significant health problem where current therapy management still possesses risks. Thrombus resolution during natural DVT progression involves various leukocyte influx and pro-inflammatory responses. Chondroitin sulfate glycosaminoglycans (CS-GAGs), linear polysaccharides found on blood vessel endothelium and leukocyte cell surfaces, have been reported to regulate leukocyte trafficking in several inflammatory diseases. Furthermore, GAG chain function depends on the alteration in GAG chain length or sulfation. One of the involved enzymes is Chondroitin Sulfate N-acetylgalactosaminyltransferase-2 (ChGn-2), an enzyme which is able to elongate GAG chain. In humans, the ChGn-2 gene is expressed widely, implying that ChGn-2 might play roles in various mechanisms throughout the body. Nonetheless, ChGn-2 role in the pathology of DVT remains unclear. Methods and results: We investigated ChGn-2 role in DVT by completely ligating the inferior vena cava in 10 – 12-week-old male C57BL/6J mice (n = 25) and mice with global deletion of ChGn-2 (n = 25). We found a higher thrombus burden (p<0.0001) in day 4 and day 7 after surgery with a slower thrombus organization in the transgenic mice by Carstair staining in day 2 (p<0.05) and day 4 (p<0.01). Interestingly, loss of this gene also reduced MMP activity (p<0.001) in day 7 along with pro-inflammatory cytokines and leukocyte markers. Moreover, immunohistochemistry staining also showed that leukocytes were mostly found at the edge of the thrombus in the transgenic mice. Further examination by in vivo imaging of femoral vein ligation revealed an impaired leukocyte influx in the transgenic mice. Transferring leukocytes from WT mice into transgenic mice rescued the phenotype, while the reverse experiment led to an impaired leukocyte influx. Finally, simultaneous imaging of WT and ChGn-2 KO leukocytes revealed that WT leukocytes could infiltrate inside the thrombus but not ChGn-2 KO leukocytes, confirming that ChGn-2 in leukocytes is important in our study.. Conclusion: Insufficient CS-GAGs length caused by the loss of ChGn-2 impaired thrombus resolution due to reduced leukocyte infiltration.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4141101
Primary Topic
Proteoglycans and glycosaminoglycans research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4141101: Loss of Chondroitin Sulfate N-acetylgalactosaminyltransferase-2 (ChGn-2) Impairs Thrombus Resolution in Mice Model

Tetsuya Hara, Noriaki Emoto, Ken‐ichi Hirata, Aditya Adinata et al.
Circulation
Proteoglycans and glycosaminoglycans research
article

Abstract 4141101: Loss of Chondroitin Sulfate N-acetylgalactosaminyltransferase-2 (ChGn-2) Impairs Thrombus Resolution in Mice Model

Tetsuya Hara, Noriaki Emoto, Ken‐ichi Hirata, Aditya Adinata, Arinal Chairul Achyar
article en

Abstract

Background: Deep vein thrombosis (DVT) remains a significant health problem where current therapy management still possesses risks. Thrombus resolution during natural DVT progression involves various leukocyte influx and pro-inflammatory responses. Chondroitin sulfate glycosaminoglycans (CS-GAGs), linear polysaccharides found on blood vessel endothelium and leukocyte cell surfaces, have been reported to regulate leukocyte trafficking in several inflammatory diseases. Furthermore, GAG chain function depends on the alteration in GAG chain length or sulfation. One of the involved enzymes is Chondroitin Sulfate N-acetylgalactosaminyltransferase-2 (ChGn-2), an enzyme which is able to elongate GAG chain. In humans, the ChGn-2 gene is expressed widely, implying that ChGn-2 might play roles in various mechanisms throughout the body. Nonetheless, ChGn-2 role in the pathology of DVT remains unclear. Methods and results: We investigated ChGn-2 role in DVT by completely ligating the inferior vena cava in 10 – 12-week-old male C57BL/6J mice (n = 25) and mice with global deletion of ChGn-2 (n = 25). We found a higher thrombus burden (p<0.0001) in day 4 and day 7 after surgery with a slower thrombus organization in the transgenic mice by Carstair staining in day 2 (p<0.05) and day 4 (p<0.01). Interestingly, loss of this gene also reduced MMP activity (p<0.001) in day 7 along with pro-inflammatory cytokines and leukocyte markers. Moreover, immunohistochemistry staining also showed that leukocytes were mostly found at the edge of the thrombus in the transgenic mice. Further examination by in vivo imaging of femoral vein ligation revealed an impaired leukocyte influx in the transgenic mice. Transferring leukocytes from WT mice into transgenic mice rescued the phenotype, while the reverse experiment led to an impaired leukocyte influx. Finally, simultaneous imaging of WT and ChGn-2 KO leukocytes revealed that WT leukocytes could infiltrate inside the thrombus but not ChGn-2 KO leukocytes, confirming that ChGn-2 in leukocytes is important in our study.. Conclusion: Insufficient CS-GAGs length caused by the loss of ChGn-2 impaired thrombus resolution due to reduced leukocyte infiltration.

CirculationVol. 150(Suppl_1)
Kobe Pharmaceutical University (JP), Kobe University (JP)
Good health and well-being
Openalex Percentile: Top 79%
Proteoglycans and glycosaminoglycans research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.